HIV Articles
Back
	LA Cabotegavir & Rilpivirine During Pregnancy       Rilpivirine PK in HIV+ pregnant women   FIGURE 1. Rilpivirine median plasma concentrations over time. Nonpregnant reference exposure was determined from package insert.12 Error bars are standard error of the median.   Pdf attached Pregnancy Outcomes and Pharmacokinetics in Pregnant Women Living With HIV Exposed to Long-Acting Cabotegravir and Rilpivirine in Clinical Trials - ID Week 2021 Patel. (09/30/21)   Rilpivirine MATERNAL DOLUTEGRAVIR (DTG) USE, AND PREGNANCY AND BIRTH OUTCOMES: THE ANTIRETROVIRAL PREGNANCY REGISTRY (APR) - (09/29/21)   Long acting injectable cabotegravir: updated efficacy and safety results from HPTN 084   AIDS 2022   S Delany-Moretlwe et al. on behalf of the HPTN 084 study team           View Older Articles   Back to Top   www.natap.org